Location: Wavre, Bélgica
Area: 400 m2
Material: Estremadura, blue granite
GlaxoSmithKline invested € 340 million in Wavre in a new, state-of-the-art building entirely dedicated to the production of vaccines against Poliomyelitis. An investment that confirms GSK Belgium’s status as the largest vaccine production unit in the world.
Products & Challenges
Granite for the facade.